Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Nova Announces First Quarter 2022 Results

T.NOVC

First quarter sales growth of 171%, gross margin growth of 95%, and positive operating profit excluding transaction costs related to the Sundial-Alcanna transaction

EDMONTON, AB, May 9, 2022 /CNW/ - Nova Cannabis Inc. (the "Company" or "Nova") (TSX: NOVC) today released its unaudited condensed interim consolidated financial statements (the "interim financial statements") and management's discussion and analysis ("MD&A") for the three months ended March 31, 2022. All financial information in this press release is reported in millions of Canadian dollars and represents results from continuing operations, unless otherwise indicated.

NOVA Cannabis Inc. (CNW Group/Nova Cannabis Inc.)

"The Company's Value Buds stores experienced strong sales through the first quarter of 2022, and gross margin improved sequentially from the fourth quarter of 2021," said Marcie Kiziak, CEO of Nova. "Those results are a direct correlation of the consolidation and rationalization in the industry, which our disruptive pricing strategy was designed to withstand. It is our commitment to continue to improve operational efficiency and discipline in managing our retail stores while selling good cannabis affordably. With the deep support and increased capital commitment from Sundial, our new majority shareholder, Nova is well positioned to extend its leadership position in Alberta, expand in Ontario, and continue our trajectory as one of Canada's largest and fastest growing cannabis retailers by bringing best value prices to the heart of the cannabis market and encouraging greater migration from the illicit market."

FINANCIAL AND OPERATING HIGHLIGHTS
  • Sales of $49.8 million, a 171% increase from the first quarter of 2021, and a 5% increase from the fourth quarter of 2021.
  • Gross margin of $9.4 million, or 19% of sales, a 95% increase from the first quarter of 2021 and an improvement as a percentage of sales from 18% for the fourth quarter of 2021.
  • Nova now has 80 stores open, an increase of six stores since January 1, 2022.
  • Operating loss before depreciation, impairment and other costs of $0.2 million compared to $0.1 million for the first quarter of 2021. Which included $1.6 million of costs that were incurred as a result of the closing of the Sundial-Alcanna Transaction (described below) relating to D&O insurance, severance, accelerated share-based payment expense and legal fees.
  • Increased revolving credit facility from a maximum of $5 million to a maximum of $10 million.
  • Cash of $4.9 million as at March 31, 2022.
  • Nova appointed Marcie Kiziak as its Chief Executive Officer on March 31, 2022.
SUNDIAL ACQUISITION OF ALCANNA

On October 7, 2021, Sundial Growers Inc. ("Sundial") (NASDAQ: SNDL) entered into an arrangement agreement, as amended, to acquire all of the issued and outstanding common shares of Alcanna Inc. ("Alcanna"), Nova's majority shareholder (the "Sundial-Alcanna Transaction").

On March 31, 2022, Alcanna and Sundial completed the Sundial-Alcanna Transaction, and Sundial indirectly acquired an approximately 63% ownership interest in Nova, as Alcanna was the registered holder of 35,750,000 Nova common shares on March 31, 2022. Sundial is now Nova's majority shareholder.

FIRST QUARTER 2022 FINANCIAL RESULTS
Sales

Sales increased 170.9% compared to the first quarter of 2021, to $49.8 million from $18.4 million. The increase is primarily due to the 27 retail cannabis stores that were opened since March 31, 2021, the 19 stores acquired late in the first quarter of 2021 as part of the business combination between YSS Corp. and Alcanna, and increased sales from stores that were re-branded to the Value Buds discount banner from "Nova Cannabis," "YSS," and "Sweet Tree" at various times throughout 2021.

Gross margin

Gross margin for the period was $9.4 million, up $4.6 million or 95.4%, from $4.8 million for the same period in the prior year. The gross margin as a percent of sales was 18.8% for the period compared to 26.0% in the first quarter of 2021. During the comparative period for 2021, the stores were operated under the Nova Cannabis, YSS and Sweet Tree banners with a different operating, pricing and margin strategy than in the first quarter of 2022 when sales came primarily from the stores converted to the Value Buds discount banner.

Operating loss before depreciation, impairment and other costs

Operating loss before depreciation, impairment and other costs for the three months ended March 31, 2022 was $0.2 million compared to $0.1 million in the first quarter of 2021. Included in this loss was $1.6 million of costs that were incurred as a result of the closing of the Sundial-Alcanna Transaction relating to D&O insurance, severance, accelerated share-based payment expense and legal fees. Excluding these expenses, the increased profit before depreciation, impairment and other costs is primarily a result of the increase in sales and gross margin for the three months ended March 31, 2022.

Net loss and comprehensive loss

For the three months ended March 31, 2022, the Company recorded a net loss of $3.5 million compared to a $2.2 million net loss in the first quarter of 2021. Included in this loss was $1.6 million of costs that were incurred as a result of the closing of the Sundial-Alcanna Transaction relating to D&O insurance, severance, accelerated share-based payment expense and legal fees. Excluding these expenses, the reduced net loss that would have resulted but for the costs associated with the Sundial-Alcanna Transaction is primarily a result of the increase in sales and gross margin for the three months ended March 31, 2022.

LIQUIDITY AND CAPITAL RESOURCES

Summary of Consolidated Cash Flows


Three months ended


March 31,

(expressed in thousands)

2022

(unaudited)

2021

(unaudited)

Cash used in operating activities

(5,913)

(2,530)

Cash used in investing activities

(2,859)

(500)

Cash provided by financing activities

3,162

39,359

Net (decrease) increase in cash

(5,610)

36,329

Revolving Credit Facility

Effective November 1, 2020, Nova Cannabis Stores Limited Partnership ("NCS LP"), a wholly-owned subsidiary of Nova, entered into an uncommitted revolving credit facility with Alcanna, which as of March 31, 2022 is now a wholly-owned subsidiary of Sundial, in an aggregate principal amount not to exceed $5.0 million (the "Credit Facility"), unless increased to a maximum revolving facility amount of $10.0 million upon prior written notice to, and approval from, Alcanna. On May 2, 2022, Nova and Alcanna agreed to increase the aggregate principal amount of the Credit Facility to $10.0 million. As at May 9, 2022, $5.0 million in principal and accrued but unpaid interest is outstanding on the Credit Facility.

CONFERENCE CALL

Nova will host a conference call and webcast at 11 a.m. EDT (9 a.m. MDT) on Tuesday, May 10, 2022.

Call Access

Canada: 1-800-319-4610

International: +1-604-638-5340

Webcast Access

To access the live webcast of the call, please visit the following link:

https://services.choruscall.ca/links/novacannabis2022q1.html

Replay

The webcast archive will be available for three months via the link provided above.

A telephone replay will be available for one month. To access the replay dial:

Canada/USA Toll Free: 1-800-319-6413 or International Toll: +1-604-638-9010

When prompted, enter Replay Access Code: 8961#

For further information, refer to the Company's interim financial statements and MD&A for the three months ended March 31, 2022, which are available from the Company's profile on SEDAR, at www.sedar.com, or on the Company's website at www.novacannabis.ca.

FORWARD LOOKING STATEMENTS

This news release contains forward-looking statements or information (collectively "forward-looking statements") within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "continue", "anticipate", "will", "should", "plan", "intention", and similar words suggesting future events or future performance. All statements and information other than statements of historical fact contained in this news release are forward-looking statements. In particular, this news release contains forward-looking statements pertaining to: the Company's expectations regarding its growth and business strategies; its competitive position in Alberta; Ontario expansion; store openings; and the impact the closing of the Sundial-Alcanna Transaction will have on Nova's growth and business strategies.

With respect to forward-looking statements contained in this news release, the Company has made assumptions regarding, among other things: the Company's ability to identify locations for, construct and open new stores and the costs related thereto; the availability of hardware and equipment for those stores; government regulation and applicable laws will not change in a manner adverse to the Company; receipt of necessary regulatory approvals to open new stores; the Company's ability to obtain leases for new sites and attract the necessary personnel to operate new stores; demand for the products the Company sells; other factors that will drive sales growth in the Value Buds banner; availability of acquisition opportunities; sustainability of competitors' businesses and competition in the retail cannabis industry, including from the illicit cannabis market; consumer demands; and factors that influence consumer behavior.

Although the Company believes that the expectations reflected in the forward-looking statements, and the assumptions on which such forward-looking statements are made, are reasonable, especially given the unprecedented uncertainty of the full extent and impact of COVID-19, there can be no assurance that such expectations and assumptions will prove to be correct. Readers should not place undue reliance on forward-looking statements included in this news release. Forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that may cause actual performance and financial results to differ materially from any estimates, forecasts or projections. These risks and uncertainties include, among other things, the duration and severity of the COVID-19 pandemic on the business, operations and financial condition of the Company; the risk that Nova will be unable to execute its strategic plan and growth strategy, as planned without significant adverse impacts from various factors beyond its control; business decisions and strategies of Sundial, Nova's indirect majority shareholder; dependence on suppliers; potential delays or changes in plans with respect to capital expenditures and the availability of capital on acceptable terms; risks inherent in the retail cannabis industry; competition for, among other things, customers, supply, capital and skilled personnel; changes in labour costs and markets; incorrect assessments of the value of acquisitions; general economic and political conditions in Canada (including Alberta, Ontario and Saskatchewan), and globally; industry conditions, including changes in government regulations; fluctuations in foreign exchange or interest rates; unanticipated operating events; failure to obtain regulatory and third–party consents and approvals when required; changes in tax and other laws that affect us and our shareholders; the potential failure of counterparties to honour their contractual obligations; stock market volatility; and the other factors described in the Company's public filings available at www.sedar.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive.

The forward-looking statements contained in this news release are made as of the date hereof. Except as expressly required by applicable securities legislation, Nova does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

SOURCE Nova Cannabis Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2022/09/c5003.html

Tags: